Eightco Holdings appoints Caiano to board of directors
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 28 2025
0mins
Should l Buy ?
Appointment Announcement: Eightco has appointed Nicola Caiano to its Board of Directors, enhancing the company's leadership team.
Expertise and Current Role: Caiano brings over 30 years of experience in financial strategy and investment management, and he is currently the Chief Financial Officer at Cytometric Therapeutics.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
